BI 695501 DEMONSTRATES SIMILAR EFFICACY AND COMPARABLE SAFETY TO ADALIMUMAB REFERENCE PRODUCT IN PATIENTS WITH ACTIVE CROHN'S DISEASE: FINAL ANALYSIS OF THE PHASE III VOLTAIRE-CD STUDY

Hanauer, SB; Schreiber, S; Balser, SE; Brockstedt, E; Moschetti, V; Liedert, BJ

GASTROENTEROLOGY, 2020; 158 (6): S1192